PETALING JAYA: UMediC Group Bhd
(UMC) is remaining “highly optimistic” of the outlook of its long-term growth trajectory.
In a filing with Bursa Malaysia, the medical devices manufacturer said this positive momentum is fuelled by a rising demand for facility upgrades, the expansion of healthcare tourism, and the critical need to resolve overcrowding in public hospitals.
For its second quarter ended Jan 31, 2026, UMC’s net profit rose to RM2mil from RM1.89mil in the previous corresponding period, while revenue in the second quarter grew to RM13.41mil from RM11.58mil a year earlier.
UMC said the improved performance was contributed by its manufacturing segments.
For the six-month period ended Jan 31, 2026, UMC’s net profit stood at RM3.78mil compared with RM3.74mil in the previous corresponding period, while revenue rose to RM27.57mil compared with RM24.63mil a year earlier.
“Along with the Ministry of Health’s increase in allocation to RM46.5bil for Budget 2026 and an additional RM40bil earmarked through 2030 under the 13th Malaysia Plan, UMC is operating in an exceptionally favourable environment.”
